Desk›Healthcare› Procter & Gamble Health Ltd
Procter & Gamble Health Ltd
BSE 500126 · NSE PGHL · ISIN INE199A01012 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹5,731.30
-0.60%
BSE close, 28 August 2026
₹9,513.60 cr
1.7 cr shares · Small cap
₹4,548.86 cr
as published
26.7× · 15.58×
EPS ₹215.00 · BV ₹367.86
1,407.97 / 326.91
₹ cr, as filed
15
3 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -17.6% |
|---|---|
| Against 52-week low | +22.0% |
| Day change | -0.60% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹215.00 |
|---|---|
| Price / earnings | 26.66× |
| Price / book | 15.58× |
| Book value — derived, price ÷ P/B | ₹367.86 |
| Return on equity | 58.46% |
| Operating margin | 37.19% |
| Net margin | 26.44% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 58.44%
- ROE as published
- 58.46%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 363.71 | 96.15 | 57.92 | 37.19% | 26.44% |
| Mar-26 · Q | 370.45 | 94.60 | 56.99 | 37.68% | 25.54% |
| FY25-26 | 1,407.97 | 326.91 | 196.94 | 33.67% | 23.22% |
Quarter on quarter
- Revenue, quarter on quarter
- -1.8%
- Net profit, quarter on quarter
- +1.6%
- Operating margin, quarter on quarter
- -49 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 4 |
| General | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 3 selected · busiest 2026-08-12
Filing rhythm · the twelve most recent
2026-08-102026-10-07
SelectedProcedural
Filings
15 in the window · 9 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached signed Certifiacte for confirming compliance under Regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting
Procter & Gamble Health Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited financial ....
Board Meeting / Board Meeting View filing →
-
25 September 2026 ·
Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1, 2026 until 48 hours from the publication ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization
Stock Exchange is informed about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization.
Company Update / General View filing →
-
4 September 2026 ·
Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company.
The shareholders at their AGM held on September 3, 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15, 2026.
Company Update / General View filing →
-
4 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizers Report and E-Voting results for the Annual General Meeting held on September 3, 2026.
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Enclosed a summary of proceedings of the Annual General Meeting held today, viz., September 3, 2026.
AGM/EGM / AGM View filing →
-
12 August 2026 ·
59Th Annual General Meeting Of The Company
The 59th Annual General Meeting of the Company is scheduled on Thursday, September 3, 2026 at 2:30 PM.
AGM/EGM / AGM View filing →
-
12 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
The BRSR Report for the Financial Year ended March 31, 2026 is enclosed.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
12 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3, 2026.
Others / Reg. 34 (1) Annual Report View filing →
-
12 August 2026 ·
Notice Calling The 59Th Annual General Meeting Of The Company.
Enclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on Thursday, September 3, 2026 at 2:30 p.m.
AGM/EGM / AGM View filing →
-
10 August 2026 ·
Record Date For Purpose Of Dividend
Record Date for Purpose of Dividend
Corp. Action / Record Date View filing →
-
6 August 2026 ·
Press Release / Media Release
Press Release on the Unaudited Financial Results for the Quarter ended June 30, 2026.
Company Update / Press Release / Media Release View filing →
-
6 August 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Unaudited Financial Results for the Quarter ended June 30, 2026
Result / Financial Results View filing →
-
6 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting.
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Procter & Gamble Health Ltd · the 50 most recent filings